Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT02024802
Eligibility Criteria:
Inclusion Criteria:
* Participants must be in the range of 18 to 85 years of age as confirmed by state identification or passport presented upon completion of the informed consent.
* Participants must have a diagnosis indicative of either Neuropathic or Nociceptive Pain as confirmed with the prescribing medical provider.
* Participants must be starting a new regimen of transdermal (topic) pain therapy with multiple compounded reagents as indicated on prescription from medical provider
* Participants must be willing to participate in the study for a minimum of 12 weeks
* Participants must be able to provide written informed consent.
* Participants must be able to read and understand the english language
Exclusion Criteria:
* Participants must not have prior hypersensitivity or adverse events to any components of the customized prescription as indicated by their allergy history given upon registration at the pharmacy.
* Participants must not be pregnant or planning to become pregnant within the 12 week study period and must not be breastfeeding.
* Participants must not have a diagnosis for cancer in the last 5 years.
* Participants legally authorized representative (LAR) will not be a substitute for the participants' written informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT02024802
Study Brief:
Protocol Section:
NCT02024802